Select Committee on Health Minutes of Evidence


Examination of Witnesses (Questions 320 - 337)

THURSDAY 16 MARCH 2006

PROFESSOR JOHN APPLEBY, MR JAMES JOHNSON, DR PAUL MILLER, DR SALLY RUANE AND MR DANIEL EAYRES

  Q320  Chairman: Do they?

  Mr Johnson: There are one or two examples, and it is only one or two so far. There was one of orthopaedics in Southampton where the NHS unit closed because the patents were being sent to an ISTC in Salisbury. The only thing that closed was the orthopaedic unit so you could argue that you simply transferred the venue from where the orthopaedic surgery was done. Potentially it could go either way, you could have a whole hospital threatened because a lot of its surgical income would be taken away.

  Q321  Chairman: It is highly unlikely to have A&E taken into this process. We had people from the profession sitting there last week who said it made good sense to take elective surgery away from A&E because of the potential for A&E to disturb elective surgery because of incidents that happen on our roads and elsewhere during the day. You are not saying doing that would threaten it in that way, surely not?

  Mr Johnson: I would see it destabilising it because it would remove a sufficient chunk of the hospital's basic finance that the hospital might conceivably become unviable.

  Q322  Chairman: The other thing that was said earlier on was is their influence innovative on the National Health Service. Do you think any of your members have changed their work practice because they have had an ISTC in the neighbourhood?

  Mr Johnson: Some of them have gone to work for them in their spare time. I have no evidence that the practice has changed as yet. I would expect the change to be more along the lines I was talking about before to Dr Stoate of providing services that make the service more attractive to patients.

  Q323  Chairman: I accept that. One of the issues was about influencing what is happening inside the NHS.

  Mr Johnson: There was a case in, I think it was, Yarmouth over the orthopaedic surgeon who decided to run a production line and as one patient wound up in one theatre the next was put to sleep in the next theatre and he just went from one to the other. I am quite sure that was in response to the need to be productive and efficient but whether or not you could say that is a broad trend that is happening is rather unlikely at the moment.

  Q324  Chairman: I think he was trained in France, was he not? Do you think that is a good idea?

  Mr Johnson: There are arguments on both sides. The most dangerous time with an anaesthetic is when you are putting the patient to sleep and when you are waking them up. If you take your eye off the ball to put another patient to sleep at the same time you potentially have two crises going on at the same time. These things are not simple, you have got to have enough staff to do it with.

  Q325  Chairman: From what I read it was the surgeon who was moving. The Secretary of State has been using it quite regularly in her speeches.

  Mr Johnson: She has indeed. You need to have an extra anaesthetist to allow the surgeon to do that. If you are doing it without an extra anaesthetist it is probably not safe, but if you do it is safe.

  Q326  Chairman: Dr Miller, you have got something to say.

  Dr Miller: You asked about innovation and destabilisation. I think one of the ISTC representatives at the first session this morning said that he did not think there was anything truly unique or innovative that was not done anywhere in the NHS that was being done in their centres. I think it is important to remember that the NHS is innovative. It is not like the NHS has never changed or thought of anything new in the last 50/60 years. Treatment centres were developed in the NHS, the NHS had them before ISTCs. The NHS has made lots of innovations over the years. I do not like this atmosphere that is sometimes generated that the NHS has never had an original idea in the last 60 years, it is not true and it is not fair. As for destabilisation, the point has been made repeatedly today that we are still at the very, very early stage of the ISTC programme. ISTCs are doing what they were asked to do in a political and economic sense. They were never asked to do training so they have not done it. In Wave 2 they are being asked to do training and I am sure they will do it. As for the destabilisation, we have seen a small number of examples of where work has been handed over from an NHS unit to a treatment centre, not by patient choice, and that has destabilised or caused a service to close down or run down to some extent. As it takes off and there are many more treatment centres it is likely that there will be more destabilisation of NHS services but more particularly as we get into Phase 2, which is currently being tendered, where it is not just going to be orthopaedics and eyes, Wave 2 talks about gynaecology, urology, ENT, plastic surgery, cardiology, renal dialysis, a much broader range of services. It is highly likely that the destabilisation and knock-on effects on traditional NHS hospitals will be hugely greater once that is fully up and running.

  Q327  Chairman: Do you think that is a threat?

  Dr Miller: I think it is inevitably a threat.

  Q328  Chairman: If you have got a surgeon who is running two theatres, okay he has got to have a lot more support staff and everything else, and that surgeon might be used for an hour during that four hour process and an hour in a neighbouring one as well, surely that is of more benefit to the organisation, and particularly the patients, in as much as you are going to get into the theatre quicker if you have got surgeons delivering two forms of services at the same time.

  Mr Johnson: All other things being equal, yes.

  Q329  Chairman: I realise that and it may not be. That should not be perceived as a threat, it is a way that things may move in the future.

  Dr Miller: What I meant by a threat was even if by patient choice only 10% of patients looking for elective surgery chose, even just out of curiosity, to go to an ISTC, first that would not be surprising, I think the evidence is a lot of ISTCs do these things well that the NHS has not done well and give an attractive offering, the loss of 10% of elective income would be hugely destabilising for the NHS unit.

  Q330  Dr Taylor: We have heard a lot about the importance of integration and the value of integration between the NHS and the independent sector treatment centres. Have you any examples of useful interaction taking place already?

  Mr Johnson: Not yet. I work in a hospital where there is one being built in the back yard, sort of thing. One of the two principal limiting factors in my NHS hospital that is slowing down everything is lack of radiology. We have a complement of about 50% of the number of radiologists we ought to have. People stay in bed in hospital for days waiting for their ultrasound scan or something, a total waste of NHS money and their time. This new treatment centre, which is only going to have 40 beds, is going to be orthopaedics. It has got three general radiology rooms, a CT room and an MRI room. It is going to be 100 yards across from us. It will be hugely underused from the point of view of the treatment centre firm. I cannot believe that we could not jointly use that facility so that they would get more money for using it and we would have access to radiology and become a lot more efficient as a hospital. These seem to be the sorts of examples where everybody gains from a bit of co-operation.

  Q331  Dr Taylor: The crucial question was really brought up by one of the independent sector people this morning, the question of salaries. Would NHS consultants be prepared to take a session on as part of their job plan under the NHS to work in that sector? Would that be possible, would that be practicable, or would they insist on the scale of salaries in private practice?

  Mr Johnson: I think in this instance it would be rather the other way around. We would be looking for their radiologists to come and work in the NHS, in which case we would presumably offer them NHS rates. I think these are negotiable. Frankly, if a surgeon or anaesthetist decides in his own time that instead of going to do some private practice on a Saturday morning he will go and work for a treatment centre it is a matter for negotiation what the deal is and if it is not satisfactory he will not do it. It will not necessarily be NHS rates.

  Q332  Dr Taylor: We hear of NHS surgeons doing crosswords on the news because there are no facilities for them to work at that time. If they have got spare slots on their job plans could they move those spare slots into an independent sector treatment centre? It would seem obvious that they should.

  Mr Johnson: With respect, I think the reference to crossword puzzles was due to the fact that the NHS has virtually been told to stop working for the last two months of the financial year because it has run out of money. That is a whole new ballgame but it is something I would not support or excuse for a moment. It seems a very mixed message to tell you to work and be productive and efficient for the first 10 months of the year and then stop doing everything for the last two. That is just a bad system. That is what the crossword puzzles are about. If it were part of the job plan that it would be better done at the treatment centre it would be for the employer to second the consultant and say, "Rather than work for us for this session, you work there". That provision is available.

  Dr Taylor: This is a point we will take up in our workforce inquiry.

  Q333  Chairman: I am sure we will. The BMA would not have a problem with that, would they?

  Mr Johnson: Providing that the consultant was not sent against his will, no.

  Q334  Chairman: They would be going there on their NHS contract which could totally destabilise the private doctors who are working in there. You would not have a problem with that as an organisation, would you?

  Dr Miller: More than that, specifically we have been in talks and discussions and negotiations with the Department of Health to provide a framework in which such secondments could happen avoiding various pitfalls that could occur.

  Q335  Chairman: This would be effectively through local integration as opposed to national direction, is that what you are saying?

  Mr Johnson: We have no problem at all with that.

  Q336  Chairman: I think that is about it. Obviously you have had a taste of the first phase and the second phase is on the way. I think we have got most issues out of you. One thing I was going to ask was you do not see a problem with training people in ISTCs from the profession's point of view, do you, providing everything else is equal?

  Mr Johnson: It will not just happen.

  Q337  Chairman: It would slow down the activity, as training does, but you do not see a problem in relation to that?

  Mr Johnson: The problem will be that for the first time the costs of training will become transparent. It has been regarded in the NHS rather as something that you do. If the treatment centre firm says to the PCT or whoever is buying it, "Okay, you want us to train, this will cost you X extra", the PCT will say, "Hang on, we have never paid for training before, what is all this about?" It will start to make it transparent but that is probably no bad thing.

  Chairman: Sorry for the overrun. It happened in the first session and we consistently overran with the second and third as well. Thank you very much indeed for your evidence. We will at some stage be bringing out a report. Thank you.





 
previous page contents

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2006
Prepared 25 July 2006